Form 4/A for ELTX Elicio Therapeutics, Inc.
Accepted 2022-05-27 00:00:00 ET · period of report 2021-02-09 · accession 0001601485-22-000044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2022-05-27 | 2021-02-09 | ELTX | GANZI VICTOR F | Dir | X - OptEx | $6.43 | +614.3K | 1.07M | +135% | +$3.95M |
| DA | 2022-05-27 | 2021-02-09 | ELTX | GANZI VICTOR F | Dir | S - Sale+OE | $16.00 | -246.7K | 823.1K | -23% | -$3.95M |
| DA | 2022-05-27 | 2021-02-09 | ELTX | GANZI VICTOR F | Dir | X - OptEx | $0.00 | -614.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-02-09 | X | A | 614,310 | $6.43 | 1,069,837 | D | — | — | |
| 2 | Common | Common Stock | 2021-02-09 | S | D | 246,720 | $16.00 | 823,117 | D | — | — | |
| 3 | Derivative | Warrant to Purchase Common Stock | 2021-02-09 | X | D | 614,310 | $0.00 | 0 | D | $6.43 · — to 2028-07-05 | 614,310 Common Stock | (F1) On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person. |